Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673451 · ClinicalTrials.gov registry record · Phase 1
2-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects
A Phase 1 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT01673451 is a Phase 1 study that has completed, run by Eisai. The registered enrollment target is 24 participants.
The verdict
NCT01673451, a Phase 1 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a single-center, randomized, double-blind, placebo-controlled, sequential, multiple-dose study. The study will be conducted in two parts: Part A (6 cohorts of healthy adults receiving evening dosing) and Part B (one cohort of elderly adults receiving evening dosing).
Interventions
- DRUG Placebo comparator
- DRUG E2006
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01673451
The ClinicalTrials.gov registry entry for NCT01673451 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo comparator is the first listed.
NCT01673451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01673451 about?
NCT01673451 is a clinical study titled "2-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects". This is a single-center, randomized, double-blind, placebo-controlled, sequential, multiple-dose study. The study will be conducted in two parts: Part A (6 cohorts of healthy adults receiving evening dosing) and Part B (one cohort of elderly adults receiving evening dosing).
What is the current status of trial NCT01673451?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2012-08. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01673451?
The interventions under investigation include: Placebo comparator (DRUG), E2006 (DRUG).
Who is sponsoring clinical trial NCT01673451?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.